Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 2
1989 1
1991 1
1992 1
1993 1
1996 1
1997 1
1998 2
1999 2
2000 6
2001 1
2002 3
2003 4
2004 6
2005 8
2006 5
2007 5
2008 5
2010 2
2011 2
2012 2
2013 1
2014 1
2015 2
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical perspectives on bisphosphonate renal safety.
Body JJ, Pfister T, Bauss F. Body JJ, et al. Among authors: bauss f. Oncologist. 2005;10 Suppl 1:3-7. doi: 10.1634/theoncologist.10-90001-3. Oncologist. 2005. PMID: 16264106 Free article. Review.
Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy.
Bauss F, Lechmann M, Krippendorff BF, Staack R, Herting F, Festag M, Imhof-Jung S, Hesse F, Pompiati M, Kollmorgen G, da Silva Mateus Seidl R, Bossenmaier B, Lau W, Schantz C, Stracke JO, Brinkmann U, Onda M, Pastan I, Bosslet K, Niederfellner G. Bauss F, et al. Mol Oncol. 2016 Oct;10(8):1317-29. doi: 10.1016/j.molonc.2016.07.003. Epub 2016 Jul 14. Mol Oncol. 2016. PMID: 27507537 Free PMC article.
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
Kollmorgen G, Niederfellner G, Lifke A, Spohn GJ, Rieder N, Harring SV, Bauss F, Burtscher H, Lammers R, Bossenmaier B. Kollmorgen G, et al. Among authors: bauss f. Mol Oncol. 2013 Dec;7(6):1142-51. doi: 10.1016/j.molonc.2013.08.009. Epub 2013 Sep 3. Mol Oncol. 2013. PMID: 24055141 Free PMC article.
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies.
Schneider B, Grote M, John M, Haas A, Bramlage B, Ickenstein LM, Jahn-Hofmann K, Bauss F, Cheng W, Croasdale R, Daub K, Dill S, Hoffmann E, Lau W, Burtscher H, Ludtke JL, Metz S, Mundigl O, Neal ZC, Scheuer W, Stracke J, Herweijer H, Brinkmann U. Schneider B, et al. Among authors: bauss f. Mol Ther Nucleic Acids. 2012 Sep 18;1(9):e46. doi: 10.1038/mtna.2012.39. Mol Ther Nucleic Acids. 2012. PMID: 23344238 Free PMC article.
63 results